

OmniAb (NASDAQ:OABI) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of OmniAb (NASDAQ:OABI) through any online brokerage.
Other companies in OmniAb’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
OmniAb has a consensus price target of $8.00.
The stock price for OmniAb (NASDAQ: OABI) is $5.11 last updated October 30, 2026 at 5:05 PM EDT.
There are no upcoming dividends for OmniAb.
OmniAb does not have any upcoming earnings scheduled.
There is no upcoming split for OmniAb.
OmniAb is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and...